Will HLA-B27 (Human Leukocyte Antigen B27) testing by RT-PCR (Real-Time Polymerase Chain Reaction) provide quantitative results?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Yes, an HLA-B27 test performed by RT-PCR can give a quantitative result, as seen in the study by 1, which used quantitative reverse transcription-polymerase chain reaction (RT-PCR) to measure the expression of HLA-B27 mRNA in patients with ankylosing spondylitis. This study found that the expression of HLA-B27 mRNA was significantly higher in patients with ankylosing spondylitis compared to healthy controls, and that the level of expression was correlated with clinical disease activity. The use of quantitative RT-PCR allows for the measurement of the amount of HLA-B27 mRNA present in a sample, which can provide valuable information for patient management. Some key points to consider when interpreting the results of an HLA-B27 test performed by RT-PCR include:

  • The test can provide a quantitative result, which can be useful for monitoring disease activity and response to treatment
  • The test is highly specific and sensitive, making it a valuable tool for diagnosing and managing ankylosing spondylitis and other related conditions
  • The results of the test should be interpreted in the context of the patient's clinical presentation and other diagnostic findings. It's worth noting that not all RT-PCR tests for HLA-B27 are designed to provide quantitative results, and some may only provide a qualitative result (positive or negative) as seen in the studies by 2, 3, 4, and 5. However, the study by 1 demonstrates that quantitative RT-PCR can be a useful tool for measuring HLA-B27 expression and monitoring disease activity in patients with ankylosing spondylitis.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.